About 60% of pulmonary LCNEC do not exhibit the small cell hallmark signature (TP53 and Rb1 co-mutation) which might explain the large percentage of LCNEC patients who are platinum-refractory or rapidly progress on a platinum doublet. The gene discussed is RB1; the disease is large cell neuroendocrine carcinoma.